Aexiqual
Quality and sterilisation validation consulting for pharmaceutical, biotech, medical-device and cosmetics industries
Highlights
- New on EvolcAdded 2026-11-14
About Aexiqual
AExiqual provides consulting and support to health-industry companies, including biotech firms, pharmaceutical laboratories, medical-device and cosmetics manufacturers, and their suppliers. Its expertise covers pharmaceutical and quality standards, and it holds exploitation rights for a patent on a sterilisation-validation method.
The company also works with high-pressure sterilisation processes, including high-pressure hydrostatic sterilisation. AExiqual is based in Mérignac, France, and was founded in 2015.
Product: Consulting for health-industry companies and a patented method for validating sterilisation processes.
Jobs at Aexiqual
More consulting & professional services companies
Af Conseils
Chartered accounting and statutory audit firm in Paris for artisans, very small businesses and SMEsNew on EvolcAf Gestion
Accounting, tax, payroll and business-formation services for companies in Occitanie, FranceNew on EvolcAfal Conseil
Business management consulting for small and midsize businesses in northern FranceNew on EvolcAfc Management
Industrial quality auditing, training and consulting for companies developing management systems and improvement projectsNew on EvolcAffaires Publiques Consultants
Lobbying and public-affairs consultancy advising companies, associations and start-ups on public decision-making in FranceNew on EvolcAffirma
Accounting, tax, social and legal advisory for SMEs, groups and start-ups in France and ItalyNew on Evolc
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Content delivery
- CloudflareHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.